Diet and Physical Activity Interventions to Improve Outcomes in Colorectal Cancer Survivors: A Multicenter Randomized Controlled Trial in North Africa
JCO Global Oncology · 2026
DOI: 10.1200/go-25-00649 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JCO Global Oncology, 2026. Verfasst von Wala Ben Kridis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, Sfax, Tunisia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Exercise, Diet, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
PURPOSE The aim of this study is to evaluate the effectiveness of a culturally adapted lifestyle intervention that combines diet and physical activity (PA) in improving survival outcomes and quality of life among colorectal cancer (CRC) survivors in North Africa. METHODS A multicenter, randomized, controlled phase II trial with a 2 × 2 factorial design enrolled 300 nonmetastatic CRC survivors in remission across three oncology centers. Participants were randomly assigned into four groups: combined diet + PA, diet-only, PA-only, or usual care. Interventions were delivered for 12 months, with outcomes assessed at 24 months. Primary end points were changes in dietary behaviors and PA levels; secondary end points included disease-free survival (DFS), overall survival (OS), and quality of life (FACT-G). RESULTS The primary end points were achieved, with significant improvements in moderate-to-vigorous PA and dietary behaviors at 12 and 24 months across all intervention groups compared with usual care ( P < .001), with the greatest and most sustained effects observed in the combined diet and PA arm. At 24 months, the combined intervention group demonstrated a 75% reduction in recurrence risk (hazard ratio [HR], 0.25 [95% CI, 0.08 to 0.78]; P = .01) and an 82% reduction in mortality (HR, 0.18 [95% CI, 0.04 to 0.78]; P = .01) compared with usual care. Diet-only and PA-only arms showed favorable but nonsignificant trends. Quality-of-life scores (FACT-G) improved across all intervention groups, with the greatest gains in the combined intervention arm. Subgroup analyses revealed consistent effects across age, sex, comorbidity status, tumor site, and cancer stage. CONCLUSION Structured, culturally adapted lifestyle interventions integrating diet and PA significantly enhance survival and quality of life in CRC survivors, with the greatest benefits observed in the combined intervention group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, Sfax, Tunisia.
- Pathology Department at Azzytuna University, Tarhuna, Libya.
- Genetics, Agriculture Research and Food Products, Authority Center, Misurata, Libya.
- Department of Reconstructive Surgery, National Institute Oncology, Misurata, Libya.
- Department of Medical Oncology, National Institute Oncology, Misurata, Libya.
ORCID-Profile: Wala Ben Kridis
Zitieren
APA
Ben Kridis, W., Aboturkia, A. M., Aqoup, M. O., Abdoalmola, M. O., Ben Ali, S., & Khanfir, A. (2026). Diet and Physical Activity Interventions to Improve Outcomes in Colorectal Cancer Survivors: A Multicenter Randomized Controlled Trial in North Africa. JCO Global Oncology. https://doi.org/10.1200/go-25-00649
Vancouver
Ben Kridis W, Aboturkia AM, Aqoup MO, Abdoalmola MO, Ben Ali S, Khanfir A. Diet and Physical Activity Interventions to Improve Outcomes in Colorectal Cancer Survivors: A Multicenter Randomized Controlled Trial in North Africa. JCO Global Oncology. 2026. doi:10.1200/go-25-00649
BibTeX
@article{BenKridis2026,
author = {Ben Kridis, Wala and Aboturkia, Ali Mohamed and Aqoup, Mukhtar Omer and Abdoalmola, Munir Omer and Ben Ali, Suhil and Khanfir, Afef},
title = {Diet and Physical Activity Interventions to Improve Outcomes in Colorectal Cancer Survivors: A Multicenter Randomized Controlled Trial in North Africa},
journal = {JCO Global Oncology},
year = {2026},
doi = {10.1200/go-25-00649}
}
EUVIMED